Nanobody-Based CAR Targeting of an Endogenous Retroviral Envelope for the Treatment of Glioblastoma

被引：0
|
作者：
Majdoul, Saliha [1 ]
Li, Wenxue [2 ]
Sampson, Kevon [2 ]
Wilson, Kari [1 ]
Seetharam, Deepa [3 ]
Nellan, Anandani [1 ]
Shah, Ashish H. [3 ]
Nath, Avindra [2 ]
Taylor, Naomi [1 ]
机构：
[1] NCI, Ctr Canc Res, Pediat Oncol Branch, NIH, Bethesda, MD USA
[2] NINDS, NIH, Bethesda, MD USA
[3] Univ Miami, Dept Neurosurg, Sch Med, Miami, FL USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1803.
引用
收藏
页码：841 / 841
页数：1
相关论文
共 50 条
  • [41] Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours
    Dan Li
    Ruixue Wang
    Tianyuzhou Liang
    Hua Ren
    Chaelee Park
    Chin-Hsien Tai
    Weiming Ni
    Jing Zhou
    Sean Mackay
    Elijah Edmondson
    Javed Khan
    Brad St Croix
    Mitchell Ho
    Nature Communications, 14 (1)
  • [42] CD7 Nanobody-Based Immuno-Nanotoxin for Targeted Treatment of T-Cell Acute Lymphoblastic Leukemia
    Dong, Yangyang
    You, Fengtao
    Zhang, Yifan
    Sun, Huanli
    Cheng, Ru
    Zhao, Songsong
    Yang, Lin
    Zhong, Zhiyuan
    ACS APPLIED NANO MATERIALS, 2024, 7 (07) : 7195 - 7202
  • [43] Identification of syncytin-car-1, an endogenous retroviral envelope gene involved in placentation and conserved in Carnivora: a syncytin in a new superorder of placental mammals
    Guillaume Cornelis
    Odile Heidmann
    Sybille Bernard-Stoecklin
    Géraldine Véron
    Karine Reynaud
    Baptiste Mulot
    Anne Dupressoír
    Thierry Heidmann
    Retrovirology, 8 (Suppl 2)
  • [44] CAR-T cell therapy based on a TCR mimic nanobody targeting an intracellular antigen for solid cancers
    Lin, Qingqing
    Jin, Shi
    Wang, Mingjun
    MOLECULAR THERAPY ONCOLOGY, 2025, 33 (01):
  • [45] A novel nanobody-based HER2-targeting antibody exhibits potent synergistic antitumor efficacy in trastuzumab-resistant cancer cells
    Liu, Xinlin
    Luan, Linli
    Liu, Xi
    Jiang, Dingwen
    Deng, Junwen
    Xu, Jiazhen
    Yuan, Yang
    Xing, Jiyao
    Chen, Bingguan
    Xing, Dongming
    Huang, Haiming
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [46] Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs)
    Hambach, Julia
    Riecken, Kristoffer
    Cichutek, Sophia
    Schuetze, Kerstin
    Albrecht, Birte
    Petry, Katharina
    Roeckendorf, Jana Larissa
    Baum, Natalie
    Kroeger, Nicolaus
    Hansen, Timon
    Schuch, Gunter
    Haag, Friedrich
    Adam, Gerhard
    Fehse, Boris
    Bannas, Peter
    Koch-Nolte, Friedrich
    CELLS, 2020, 9 (02)
  • [47] A Nanobody-Based and TGF-β-Resistant Claudin 18.2-Specific CAR-T Generates Effective and Durable Anti-Tumor Response: A Preclinical Study
    Dong, Qi
    Yin, Wenjie
    Wang, Tao
    Yin, Manli
    Wu, Di
    Wang, Xinxin
    Cao, Wei William
    Shen, Lianjun
    MOLECULAR THERAPY, 2024, 32 (04) : 404 - 404
  • [48] TARGETING GLIOBLASTOMA WITH DNAM-1-BASED CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS
    Weiss, Tobias
    Meister, Hanna
    Weller, Michael
    Sentman, Charles
    Roth, Patrick
    NEURO-ONCOLOGY, 2019, 21 : 122 - 122
  • [49] Targeting Tumor-Associated Antigen: A Promising CAR-T Therapeutic Strategy for Glioblastoma Treatment
    Zhu, Guidong
    Zhang, Qing
    Zhang, Junwen
    Liu, Fusheng
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [50] Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates
    Jovcevska, Ivana
    Zupanec, Neja
    Urlep, Ziga
    Vranic, Andrej
    Matos, Bostjan
    Stokin, Clara Limbaeck
    Muyldermans, Serge
    Myers, Michael P.
    Buzdin, Anton A.
    Petrov, Ivan
    Komel, Radovan
    ONCOTARGET, 2017, 8 (27) : 44141 - 44158
12345